Modern approaches to the management of locally advanced cervical cancer

Abstract

The management of locally advanced cervical cancer (LACC) remains one of the most critical challenges in contemporary gynecologic oncology. While concurrent chemoradiotherapy has served as the definitive standard of care for decades, significant technological and pharmacological advancements have fundamentally altered the therapeutic landscape. This article provides a comprehensive systematic analysis of modern approaches to LACC management, specifically evaluating the transition from conventional radiological techniques to intensity-modulated radiation therapy (IMRT), image-guided adaptive brachytherapy (IGABT), and the integration of targeted immune checkpoint inhibitors. Synthesizing data from recent clinical trials and institutional retrospective cohorts, this study investigates survival metrics, local control rates, and toxicity profiles. The analysis demonstrates that the implementation of volumetric, MRI-guided brachytherapy combined with systemic PD-1 blockade drastically improves 3-year progression-free survival while simultaneously minimizing severe genitourinary and gastrointestinal adverse events. By mathematically modeling the reduction in late-stage toxicity and the enhancement of locoregional eradication, the findings emphasize the absolute necessity of updating domestic oncology protocols. Transitioning toward precision radiotherapy and immunological modulation offers a definitive pathway to maximizing long-term survivorship and preserving the physiological quality of life for female patients confronting advanced cervical malignancies.